Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis

IMPORTANCE: Patients undergoing hemodialysis have a high mortality rate associated with COVID-19, and this patient population often has a poor response to vaccinations. Randomized clinical trials for COVID-19 vaccines included few patients with kidney disease; therefore, vaccine immunogenicity is un...

Descripción completa

Detalles Bibliográficos
Autores principales: Yau, Kevin, Abe, Kento T., Naimark, David, Oliver, Matthew J., Perl, Jeffrey, Leis, Jerome A., Bolotin, Shelly, Tran, Vanessa, Mullin, Sarah I., Shadowitz, Ellen, Gonzalez, Anny, Sukovic, Tatjana, Garnham-Takaoka, Julie, de Launay, Keelia Quinn, Takaoka, Alyson, Straus, Sharon E., McGeer, Allison J., Chan, Christopher T., Colwill, Karen, Gingras, Anne-Claude, Hladunewich, Michelle A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414193/
https://www.ncbi.nlm.nih.gov/pubmed/34473256
http://dx.doi.org/10.1001/jamanetworkopen.2021.23622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414193/
https://www.ncbi.nlm.nih.gov/pubmed/34473256
http://dx.doi.org/10.1001/jamanetworkopen.2021.23622

Ejemplares similares